- Home
- KPLT vs ICCM Comparison
KPLT vs ICCM Comparison
Compare KPLT & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPLT | ICCM |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KPLT | ICCM |
|---|---|---|
| Price | $7.36 | $0.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $2.50 |
| AVG Volume (30 Days) | ★ 1.1M | 375.3K |
| Earning Date | 11-12-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $280,839,000.00 | $2,975,000.00 |
| Revenue This Year | $21.42 | $13.67 |
| Revenue Next Year | $15.48 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.15 | N/A |
| 52 Week Low | $5.08 | $0.59 |
| 52 Week High | $24.34 | $1.66 |
Technical Indicators
Market Signals| Indicator | KPLT | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 39.01 |
| Support Level | $6.00 | $0.67 |
| Resistance Level | $7.00 | $0.72 |
| Average True Range (ATR) | 0.58 | 0.03 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 35.88 | 5.66 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.